HopeStage
Back to all studies
CompletedNCT00188643

Venlafaxine compared with lamotrigine added to mood-stabilizing treatment for bipolar depression

About this titleRead the official source — NCT00188643
Medication studyAges 18–65CanadaBipolarity
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
TorontoSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2002
Recruitment status
Completed
Enrollment listed in the registry
40
Sponsor
University Health Network, Toronto
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT00188643
Official title
Show the full official title

Double-Blind, Acute Depression Study Comparing Venlafaxine XR and Lamotrigine When Added to Mood Stabilizer in the Treatment of Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Health Network, Toronto, a university.

Did this study involve medication?

Yes. The study involved medication, including Venlafaxine and Lamotrigine.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies